In the fast-growing, ever-evolving world of pharmaceuticals, few sectors are as dynamic and promising as radiopharmaceuticals. Fueled by technological advancements and a growing demand for targeted ...

Photo: Christopher Bowman (left), professor of chemical and biological engineering at the University of Colorado Boulder, holds a beaker of hydrogel as a graduate student illuminates the material with ...

Arrowhead Pharmaceuticals has a promising pipeline of drug candidates based on RNAi methodology. It has developed a tighter focus to push its most promising cardiometabolic drug (Plozasiran) toward ...

Photo: Winners of the 2024 Lab Venture Challenge competition. For faculty, staff and students at the University of Colorado engaged in research, invention or creative work, commercialization offers a ...

Thomas Healy, Founder, President, CEO & Director, said Hyliion is “positioned strongly to deploy more early adopter units and move towards commercialization.” Healy detailed that the KARNO power ...